P53 Mutations Change Phosphatidylinositol Acyl Chain Composition

Slides:



Advertisements
Similar presentations
Volume 24, Issue 5, Pages (November 2013)
Advertisements

Volume 16, Issue 5, Pages (August 2016)
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
Volume 10, Issue 8, Pages (March 2015)
Volume 22, Issue 1, Pages (January 2018)
Volume 24, Issue 3, Pages (July 2018)
Volume 11, Issue 11, Pages (June 2015)
Jennifer R. Hamilton, Gayathri Vijayakumar, Peter Palese  Cell Reports 
Volume 20, Issue 11, Pages (September 2017)
Volume 20, Issue 4, Pages (April 2013)
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Volume 30, Issue 1, Pages (April 2008)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer
Volume 8, Issue 5, Pages (May 2011)
Volume 20, Issue 2, Pages (January 2010)
Volume 24, Issue 11, Pages (June 2014)
Volume 23, Issue 1, Pages (April 2018)
Volume 17, Issue 1, Pages (September 2016)
Volume 24, Issue 13, Pages e5 (September 2018)
Hillary S. Sloane, James P. Landers, Kimberly A. Kelly 
Volume 23, Issue 4, Pages (April 2018)
Volume 14, Issue 10, Pages (March 2016)
Volume 65, Issue 1, Pages (January 2017)
Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer  Svend O Freytag, Yingshu Zhang,
Volume 7, Issue 1, Pages (April 2014)
Volume 7, Issue 6, Pages (June 2005)
Volume 22, Issue 1, Pages (January 2018)
Volume 18, Issue 9, Pages (February 2017)
Volume 6, Issue 5, Pages (March 2014)
Dysregulation of Chondrogenesis in Human Cleidocranial Dysplasia
Volume 22, Issue 3, Pages (January 2018)
Volume 25, Issue 13, Pages e2 (December 2018)
Volume 18, Issue 1, Pages (January 2017)
Volume 29, Issue 3, Pages (May 2014)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Volume 23, Issue 1, Pages (April 2018)
Expression of a microRNA-Resistant Target Transgene Misrepresents the Functional Significance of the Endogenous microRNA: Target Gene Relationship  Junyan.
Volume 19, Issue 12, Pages (June 2017)
Volume 17, Issue 4, Pages (April 2015)
Volume 22, Issue 3, Pages (January 2018)
Myc Requires Distinct E2F Activities to Induce S Phase and Apoptosis
Volume 22, Issue 3, Pages (September 2012)
Volume 9, Issue 4, Pages (November 2014)
Volume 18, Issue 9, Pages (February 2017)
Martin Mikl, Carrie R. Cowan  Cell Reports 
Volume 14, Issue 1, Pages (July 2011)
Imprinted Chromatin around DIRAS3 Regulates Alternative Splicing of GNG12-AS1, a Long Noncoding RNA  Malwina Niemczyk, Yoko Ito, Joanna Huddleston, Anna.
Volume 11, Issue 11, Pages (June 2015)
Volume 50, Issue 2, Pages (April 2013)
Volume 14, Issue 7, Pages (February 2016)
Volume 9, Issue 3, Pages (November 2014)
Volume 19, Issue 6, Pages (June 2011)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 12, Issue 4, Pages (July 2015)
Volume 7, Issue 2, Pages (August 2016)
Volume 21, Issue 6, Pages (November 2017)
Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers  Ryoichi Onozato, MD,
Volume 24, Issue 12, Pages (September 2018)
Volume 5, Issue 4, Pages (November 2013)
Volume 26, Issue 4, Pages e4 (January 2019)
Volume 26, Issue 11, Pages e4 (March 2019)
Nanog-Independent Reprogramming to iPSCs with Canonical Factors
Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4
Volume 26, Issue 4, Pages e4 (January 2019)
Volume 21, Issue 6, Pages (June 2012)
Lack of Transcription Triggers H3K27me3 Accumulation in the Gene Body
SUPT4H1 Depletion Leads to a Global Reduction in RNA
Volume 14, Issue 10, Pages (March 2016)
Volume 24, Issue 11, Pages (June 2014)
Presentation transcript:

P53 Mutations Change Phosphatidylinositol Acyl Chain Composition Adam Naguib, Gyula Bencze, Dannielle D. Engle, Iok I.C. Chio, Tali Herzka, Kaitlin Watrud, Szilvia Bencze, David A. Tuveson, Darryl J. Pappin, Lloyd C. Trotman  Cell Reports  Volume 10, Issue 1, Pages 8-19 (January 2015) DOI: 10.1016/j.celrep.2014.12.010 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 10, 8-19DOI: (10.1016/j.celrep.2014.12.010) Copyright © 2015 The Authors Terms and Conditions

Figure 1 PI Characteristics Are Unique to Disparate Cancer Cell Lines and Are Dictated by Genetics and Not Growth Factors (A) Representation of quantification of phosphoinositide abundances in the common laboratory cell lines NIH 3T3 and HeLa. Graphs are derived from two independent lipid preparations and measurements. Individual sample measurements were derived from three measurements of the same sample. The sum carbon content of both lipid fatty acids is displayed as “number of carbon atoms” (left vertical axis). Relative ion counts are normalized to the ion of observed highest abundance (right vertical axis). (B) Assessment of PI the characteristics of the HCT116 cells in both normal (10% serum) and serum-starved (0.1%) conditions. (C) Assessment of two genetically engineered cell lines derived from mouse pancreas tumors. Cancers were initiated with identical genetic lesions (Kras and Trp53 mutations) from independent mice with identical backgrounds. (D) Assessment of two independent and distinct human pancreatic adenocarcinoma cell lines. For all graphs, mean measurements of two biological replicates are displayed (error bars, ±SD). Cell Reports 2015 10, 8-19DOI: (10.1016/j.celrep.2014.12.010) Copyright © 2015 The Authors Terms and Conditions

Figure 2 PI Fingerprint of Noncancerous Tissue and Cells Assessment of PI characteristics from primary wild-type MEFs and mouse tissue obtained a resection. For MEFs, mean measurements of two biological replicates are displayed (error bars, ±SD). For tissues, mean measurements of technical triplicates are displayed (error bars, ±SEM). Animals from which tissue was taken were healthy, 7-week-old wild-type males. Blood was entire fluid containing both serum and cellular components. Cell Reports 2015 10, 8-19DOI: (10.1016/j.celrep.2014.12.010) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Initiating Genetic Events Contribute to Changes in PI Characteristics in Cancer Progression (A) Comparison of PI characteristics from normal mouse pancreas (mean measurements of technical triplicates are displayed; error bars, ±SEM) and two pancreas-cancer-derived tumor lines of each of two distinct genotypes, initiated with the genetic lesions shown (mean measurements of two biological replicates are displayed; error bars, ±SD). (B) Assessment of the PI characteristics of Trp53 null MEFs. Mean measurements of two biological replicates are displayed (error bars, ±SD). Cell Reports 2015 10, 8-19DOI: (10.1016/j.celrep.2014.12.010) Copyright © 2015 The Authors Terms and Conditions

Figure 4 p53 Mutation Is Associated with Modulation of PI Content (A) PCR amplification of p53 exons 5–8 in selected human cancer cell lines. Sequencing primers produced a single amplicon used for subsequent sequencing. (B) Sequence traces of selected cancer cell lines showing identified mutations and corresponding PI characteristics. All identified mutations were identified in the DNA-binding domain of p53. Cell Reports 2015 10, 8-19DOI: (10.1016/j.celrep.2014.12.010) Copyright © 2015 The Authors Terms and Conditions

Figure 5 p53 Mutation Modulates PI Fingerprints (A) Infection of Trp53 wild-type and Trp53wild-type/lslR270H MEFs with adenovirus encoding Cre recombinase and lipid analysis was performed blinded. In total, 12 cell lines were generated to form genetic biological replicates. Correlation of Trp53 genotype with lipid status demonstrates that levels of 36-carbon PIs (861 m/z) increase subsequent to Trp53 R270H expression. (B) Analysis of eight biological replicates of Cre-treated Trp53wild-type/lslR270H MEFs demonstrates that all lines exhibit an increase of PI 861 m/z; 861 m/z abundance in Cre-treated cells is displayed as fold-change relative to the same line prior to Cre addition. (C) Quantification of PI 861 m/z relative to the most abundant PI species (885 m/z) pre- and post-Cre addition (two-tailed t test; whiskers, ±SD). Cell Reports 2015 10, 8-19DOI: (10.1016/j.celrep.2014.12.010) Copyright © 2015 The Authors Terms and Conditions